Schmitz, Christoph; Rutten, Bart P.F.; Pielen, Andrea; Schafer, Stephanie; Wirths, Oliver; Tremp, Gunter; Czech, Christian; Blanchard, Veronique; Multhaup, Gerd; Rezaie, Payam; Korr, Hubert; Steinbusch, Harry W.M.; Pradier, Laurent and Bayer, Thomas A.
|DOI (Digital Object Identifier) Link:||http://dx.doi.org/10.1016/S0002-9440(10)63235-X|
|Google Scholar:||Look up in Google Scholar|
According to the "amyloid hypothesis of Alzheimer's disease," beta-amyloid is the primary driving force in Alzheimer's disease pathogenesis. Despite the development of many transgenic mouse lines developing abundant beta-amyloid-containing plaques in the brain, the actual link between amyloid plaques and neuron loss has not been clearly established, as reports on neuron loss in these models have remained controversial. We investigated transgenic mice expressing human mutant amyloid precursor protein APP751 (KM670/671NL and V717I) and human mutant presenilin-1 (PS-1 M146L). Stereologic and image analyses revealed substantial age-related neuron loss in the hippocampal pyramidal cell layer of APP/PS-1 double-transgenic mice. The loss of neurons was observed at sites of Abeta aggregation and surrounding astrocytes but, most importantly, was also clearly observed in areas of the parenchyma distant from plaques. These findings point to the potential involvement of more than one mechanism in hippocampal neuron loss in this APP/PS-1 double-transgenic mouse model of Alzheimer's disease.
|Item Type:||Journal Article|
|Copyright Holders:||2004 American Society for Investigative Pathology|
|Academic Unit/Department:||Science > Life, Health and Chemical Sciences
|Interdisciplinary Research Centre:||Biomedical Research Network (BRN)|
|Depositing User:||Payam Rezaie|
|Date Deposited:||12 Jun 2006|
|Last Modified:||14 Jan 2016 15:48|
|Share this page:|